Haight Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We bring you Vital Signs, a curated, one-stop resource on the most notable digital health law updates from our U.S. and global contributors.

For more than a decade, Congress, clinicians, and policymakers have been requesting implementation of a special registration pathway that would allow registered clinicians to prescribe buprenorphine without an in-person visit requirement. It's clear to us that the time to implement the pathway is now.

While this is just a temporary extension of COVID flexibilities, it can be considered a win for patients and clinicians using telemedicine.

Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.

President Biden announced he would not extend the COVID19 Public Health Emergency beyond its May 11 expiration. Tis will bring about the termination of several policy waivers and discretionary enforcement that expanded health care programs, payments, and prescribing flexibilities